Top Buy
Security | Buy | Sell | Buy (1W) ▼ | Sell (1W) | Price | Target price | Potential |
---|---|---|---|---|---|---|---|
Adverum Biotechnologies Inc. | 6 | 1 | 2 | 0 | €1.38 | €4.66 | 237.768% |
Biogen Inc. | 45 | 2 | 2 | 1 | €202.10 | €294.01 | 45.478% |
Geron Corp. | 12 | 0 | 2 | 0 | €3.65 | €4.63 | 26.838% |
Cigna Corp. | 17 | 0 | 2 | 0 | €317.25 | €342.35 | 7.912% |
Incyte Corp. | 12 | 2 | 2 | 0 | €49.94 | €78.42 | 57.033% |
Regeneron Pharmaceuticals Inc. | 34 | 1 | 1 | 0 | €889.20 | €957.22 | 7.650% |
Idexx Laboratories Inc. | 11 | 0 | 1 | 0 | €446.50 | €552.72 | 23.789% |
Alnylam Pharmace. | 36 | 0 | 1 | 0 | €141.60 | €228.30 | 61.229% |
Precision BioSciences Inc | 7 | 0 | 1 | 0 | €0.35 | €2.90 | 734.167% |
aTyr Pharma Inc | 2 | 0 | 1 | 0 | €1.44 | €10.00 | 594.444% |
Cerus Corp. | 4 | 0 | 1 | 0 | €1.51 | €3.26 | 115.649% |
Blueprint Medicines Corp | 2 | 0 | 1 | 0 | €99.52 | - | - |
Repligen Corp. | 13 | 0 | 1 | 0 | €155.15 | €184.76 | 19.085% |
Biocryst Pharmaceuticals | 8 | 0 | 1 | 0 | €4.12 | €10.96 | 165.916% |
Esperion Therapeutis.Inc. | 13 | 0 | 1 | 0 | €1.94 | €8.39 | 332.948% |
Lexicon Pharmaceuticals Inc. | 2 | 0 | 1 | 0 | €1.61 | €5.34 | 231.017% |
AnaptysBio Inc | 8 | 1 | 1 | 0 | €24.80 | €46.24 | 86.452% |
Actinium Pharmaceuticals Inc. | 4 | 0 | 1 | 0 | €8.28 | €8.50 | 2.719% |
Fate Therapeutics Inc. | 5 | 2 | 1 | 0 | €3.78 | €8.27 | 118.625% |
Cutera Inc. | 2 | 0 | 1 | 0 | €2.36 | €3.75 | 59.236% |
Fresenius Medical Care AG & Co KGaA ADR | 4 | 1 | 1 | 0 | €19.50 | €21.00 | 7.692% |
Personalis Inc | 6 | 0 | 1 | 0 | €1.50 | €3.24 | 116.640% |
ImmunityBio Inc. | 3 | 0 | 1 | 0 | €8.47 | €10.00 | 18.092% |
Pfizer Inc. | 31 | 4 | 1 | 0 | €25.85 | €41.10 | 59.006% |
Thermo Fisher Scientific Inc. | 27 | 0 | 1 | 0 | €531.60 | €568.09 | 6.865% |